Financial reports
10-K
2023 FY
Annual report
19 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
23 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
10 Mar 22
10-Q
2021 Q3
Quarterly report
9 Nov 21
Current reports
8-K
Other Events
21 Mar 24
8-K
Other Events
20 Mar 24
8-K
Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
19 Mar 24
8-K
Harrow Licenses Canadian Rights to Apotex For Five Branded Ophthalmic Pharmaceutical Products
15 Feb 24
8-K
Harrow Announces New Appointments to its Board of Directors
29 Jan 24
8-K
Melt Pharmaceuticals Provides Corporate Update
3 Jan 24
8-K
Harrow Announces Third Quarter 2023 Financial Results
13 Nov 23
8-K
Departure of Directors or Certain Officers
3 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
29 Sep 23
8-K
Harrow Announces Second Quarter 2023 Financial Results
9 Aug 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
19 Jul 23
424B5
Prospectus supplement for primary offering
18 Jul 23
8-A12B
Registration of securities on exchange
20 Dec 22
424B5
Prospectus supplement for primary offering
19 Dec 22
FWP
Free writing prospectus
16 Dec 22
424B5
Prospectus supplement for primary offering
14 Dec 22
424B5
Prospectus supplement for primary offering
14 Dec 22
S-3
Shelf registration
26 May 22
S-3
Shelf registration
3 Sep 21
S-8
Registration of securities for employees
25 Jun 21
Proxies
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
26 Apr 22
DEF 14A
Definitive proxy
26 Apr 22
DEFA14A
Additional proxy soliciting materials
19 May 21
DEFA14A
Additional proxy soliciting materials
23 Apr 21
DEF 14A
Definitive proxy
23 Apr 21
DEF 14A
Definitive proxy
24 Apr 20
Other
CERT
Certification of approval for exchange listing
20 Dec 22
EFFECT
Notice of effectiveness
7 Jun 22
CORRESP
Correspondence with SEC
1 Jun 22
UPLOAD
Letter from SEC
1 Jun 22
EFFECT
Notice of effectiveness
15 Sep 21
UPLOAD
Letter from SEC
10 Sep 21
CORRESP
Correspondence with SEC
10 Sep 21
CERT
Certification of approval for exchange listing
6 May 21
SEC STAFF
SEC staff action: Order
23 Mar 21
SEC STAFF
SEC staff action: Order
23 Feb 21
Ownership
4
Change in insider ownership
25 Apr 24
4
Change in insider ownership
24 Apr 24
4
Change in insider ownership
19 Apr 24
4
Change in insider ownership
28 Mar 24
4
MARK L BAUM
25 Mar 24
4
Change in insider ownership
22 Mar 24
4
JOHN P. SAHAREK
6 Mar 24
4
JOHN P. SAHAREK
21 Feb 24
4
ANDREW R. BOLL
21 Feb 24
4
MARK L BAUM
21 Feb 24